1. Holmes L.B., Driscoll S.G., Atkins L. Etiologic heterogeneity of neural-tube defects // N. Engl. J. Med. 1976. Vol. 294, N 7. P. 365–369. DOI: 10.1056/NEJM197602122940704.
2. Gabbe S.G. Pregnancy in women with diabetes mellitus. The beginning // Clin. Perinatol. 1993. Vol. 20, N 3. P. 507–515.
3. Hod M., Jovanovic L.G., Di Renzo G.C., de Leiva A. Textbook of diabetes and pregnancy. 2nd еd. CRC Press, 2008.
4. Zabihi S., Loeken M.R. Understanding diabetic teratogenesis: where are we now and where are we going? // Birth Defects Res. A Clin. Mol. Teratol. 2010. Vol. 88, N 10. P. 779–790. DOI: 10.1002/bdra.20704.
5. Agha M.M., Glazier R.H., Moineddin R., Booth G. Congenital abnormalities in newborns of women with pregestational diabetes: a time-trend analysis, 1994 to 2009 // Birth Defects Res. A Clin. Mol. Teratol. 2016. Vol. 106, N 10. P. 831–839. DOI: 10.1002/bdra.23548.
6. Billionnet C., Mitanchez D., Weill A., Nizard J., Alla F., Hartemann A., Jacqueminet S. Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012 // Diabetologia. 2017. Vol. 60, N 4. P. 636–644. DOI: 10.1007/s00125-017-4206-6.
7. Liu S., Rouleau J., León J.A., Sauve R., Joseph K.S., Ray J.G. et al. Impact of pre-pregnancy diabetes mellitus on congenital anomalies, Canada, 2002–2012 // Health Promot. Chronic. Dis. Prev. Can. 2015. Vol. 35, N 5. P. 79–84. DOI: 10.24095/hpcdp.35.5.01.
8. Parimi M., Nitsch D. A Systematic review and meta-analysis of diabetes during pregnancy and congenital genitourinary abnormalities // Kidney Int. Rep. 2020. Vol. 5, N 5. P. 678–693. DOI: 10.1016/j.ekir.2020.02.1027.
9. Kappen C., Salbaum J.M. Gene expression in teratogenic exposures: a new approach to understanding individual risk // Reprod. Toxicol. 2014. Vol. 45. P. 94–104. DOI: 10.1016/j.reprotox.2013.12.008.
10. HAPO Study Cooperative Research Group, Metzger B.E., Lowe L.P., Dyer A.R., Trimble E.R., Chaovarindr U. et al. Hyperglycemia and adverse pregnancy outcomes // N. Engl. J. Med. 2008. Vol. 358, N 19. P. 1991–2002. DOI: 10.1056/NEJMoa0707943.
11. Wahabi H., Fayed A., Esmaeil S., Mamdouh H., Kotb R. Prevalence and Complications of Pregestational and Gestational Diabetes in Saudi Women: Analysis from Riyadh Mother and Baby Cohort Study (RAHMA) // Biomed. Res. Int. 2017. Vol. 2017. P. 6878263. DOI: 10.1155/2017/6878263.
12. Floris I., Descamps B., Vardeu A., Mitić T., Posadino A.M., Shantikumar S. et al. Gestational diabetes mellitus impairs fetal endothelial cell functions through a mechanism involving microRNA-101 and histone methyltransferase enhancer of zester homolog-2 // Arterioscler Thromb. Vasc. Biol. 2015. Vol. 35, N 3. P. 664–674. DOI: 10.1161/ATVBAHA.114.304730.
13. Ornoy A., Reece E.A., Pavlinkova G., Kappen C., Miller R.K. Effect of maternal diabetes on the embryo, fetus, and children: congenital anomalies, genetic and epigenetic changes and developmental outcomes // Birth Defects Res. C. Embryo. Today. 2015. Vol. 105, N 1. P. 53–72. DOI: 10.1002/bdrc.21090.
14. Liu S., Evans J., MacFarlane A.J., Ananth C.V., Little J., Kramer M.S., Joseph K.S. Association of maternal risk factors with the recent rise of neural tube defects in Canada // Paediatr. Perinat. Epidemiol. 2019. Vol. 33, N 2. P. 145–153. DOI: 10.1111/ppe.12543.
15. Rudge M.V., Calderon I.M., Ramos M.D., Abbade J.F., Rugolo L.M. Perinatal outcome of pregnancies complicated by diabetes and by maternal daily hyperglycemia not related to diabetes. A retrospective 10-year analysis // Gynecol. Obstet. Invest. 2000. Vol. 50, N 2. P. 108–112. DOI: 10.1159/000010293.
16. White P. Pregnancy complicating diabetes // Am. J. Med. 1949. Vol. 7, N 5. P. 609–616. DOI: 10.1016/0002-9343(49)90382-4.
17. Евсюкова И.И., Кошелева Н.Г. Сахарный диабет: беременные и новорожденные. Москва: Миклош, 2009. 272 с.
18. Айламазян Э.К., Абашова Е.И., Коган И.Ю. и др. Сахарный диабет и репродуктивная система женщины: руководство для врачей. Москва: ГЭОТАР-Медиа, 2019. 432 с.
19. Allen V.M., Armson B.A.; GENETICS COMMITTEE; MATERNAL FETAL MEDICINE COMMITTEE. Teratogenicity associated with pre-existing and gestational diabetes // J. Obstet. Gynaecol. Can. 2007. Vol. 29, N 11. P. 927–934. DOI: 10.1016/S1701-2163(16)32653-6.
20. Hunter L.E., Sharland G.K. Maternal gestational diabetes and fetal congenital heart disease: an observational study // J. Pregnancy Child. Heal. 2015. Vol. 2. DOI: 10.4172/2376-127X.1000132.
21. Ahmed B., Abushama M., Khraisheh M., Dudenhausen J. Role of ultrasound in the management of diabetes in pregnancy // J. Matern. Neonatal. Med. 2015. Vol. 28. P. 1856–1863. DOI: 10.3109/14767058.2014.971745.
22. International Diabetes Federation. IDF Diabetes Atlas, 9th ed. Brussels, 2019.
23. Mills J.L., Simpson J.L., Driscoll S.G., Jovanovic-Peterson L., Van Allen M., Aarons J.H. et al. Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception // N. Engl. J. Med. 1988. Vol. 319, N 25. P. 1617–1623. DOI: 10.1056/NEJM198812223192501.
24. Аметов А.С., Соловьева О.Л. Сердечно-сосудистые осложнения при сахарном диабете: патогенез и пути коррекции // РМЖ. 2011. Т. 19. С. 1694–1699.
25. Coughlan M.T., Permezel M., Georgiou H.M., Rice G.E. Repression of oxidant-induced nuclear factor-κB activity mediates placental cytokine responses in gestational diabetes // J. Clin. Endocrinol. Metab. 2004. Vol. 89. P. 3585–3594. DOI: 10.1210/jc.2003-031953.
26. Díaz-Pérez F.I., Hiden U., Gauster M., Lang I., Konya V., Heinemann A. et al. Post-transcriptional down regulation of ICAM-1 in feto-placental endothelium in GDM // Cell Adhes. Migr. 2016. Vol. 10. P. 18–27. DOI: 10.1080/19336918.2015.1127467.